North America: North America Crohn's Disease market, driven by a high prevalence of inflammatory bowel diseases and advanced healthcare infrastructure. The United States leads the region, where there is significant demand for innovative therapies and ongoing research for treatment options. The rising number of patients diagnosed with Crohn's Disease, coupled with government support for...